BioTech/Drugs - Houston, TX, US
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
reCAPTCHA
Gmail
Apache
Google Font API
Google Tag Manager
Google Apps